Med. Pro Praxi 2009; 6(1): 38-41

Herpes zoster

prof. MUDr. Alena Pospíšilová CSc
Dermatovenerologická klinika, FN Brno

Herpes zoster is an acute viral disease with a classic clinical presentation of a unilateral eruption of herpetic vesicular lesions related to

a certain dermatome corresponding to the region of cutaneous innervation by a single spinal or cranial sensory ganglion. The disease

is caused by varicella-zoster virus (VZV) which is identical for both varicella and herpes zoster and is a member of the family of human

herpes viruses. Although caused by the same virus, varicella and herpes zoster have significantly different clinical presentations. Varicella

is the result of primary infection with VZV with antibody production, herpes zoster results from reactivation of a latent VZV in the

sensory ganglia, less commonly from reinfection. The paper deals with the basic clinical presentation of herpes zoster, characteristic

symptoms, and also less common but the more serious clinical forms and complications. Current diagnostic and therapeutic options

are discussed.

Keywords: herpes zoster, clinical presentation, diagnosis, treatment.

Published: March 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Pospíšilová A. Herpes zoster. Med. praxi. 2009;6(1):38-41.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Fitzpatrick TB, Eisen AZ, Wolf K, Freedberg JM, Austen KF. Dermatology in general medicine New York: McGraw-Hill, New 1993: 2977.
    2. Dworkin RH, Johnson RW, Breuer J, et al. Recomendantions for the management of herpes zoster. Clin. Infect. Dis. 2007; 44(Supp1): 1-26. Go to original source... Go to PubMed...
    3. Pospíšilová A, Haklová L. Klinické zkušenosti se systémovou enzymoterapií. Čs. Derm. 1999; 74(1): 17-20.
    4. Bartošová D. Infekce vyvolané virem varicella zoster a jejich terapie. Interní Med. 2008; 10: 31-34.
    5. Kundratitz K. Experimentelle Übertragung von Herpes Zoster auf den Menschen und die Beziehungen von Herpes Zoster zu Varicellen (in German). Monatsshrift Kinderheilkd 1925; 29: 516-522. Go to original source...
    6. Tyzzer EE. The histology of the skin lesions in varicella. Philippine J Sci 1906; 1: 349-372.
    7. von Bókay J. Über denätiologischen Zusammenhang der Varizellen mit gewissen Fällen von Herpes Zoster (in German). Wien klin Wchnschr 1909; 22: 1323-1326.
    8. Weinberg JM. Herpes zoster: epidemiology, natural history, and common complications. J. Am. Acad. Dermatol. 2007; 57(Suppl.): 130-135. Go to original source... Go to PubMed...
    9. Zoller B. Schmertztherapie - akuter Herpes zoster - Postzosterische Neuralgie. Erfarungsheilkunde 1994; 43: 243-253.
    10. Friedman-Kien AE, Lafleur FL, Gendler E, et al. Herpes zoster: A possible early clinical sign for development of acquired immunodeficiency syndrome in high-risk individuals. J. Am. Acad. Dermatol. 1986; 14: 1023-1028. Go to original source... Go to PubMed...
    11. Ragozzino MW, Melton LJ, Kurland LT, Chu CP, Perry HO. Population-based study of herpes zoster und its sequeale. Medicine 1982; 61(5): 310-316. Go to original source... Go to PubMed...
    12. Braun Falco O, Plewig G, Wolf HH. Dermatológia a venerológia. Martin; Osveta 2001: 1475.
    13. Gnann JW, Whitley RJ. Herpes zoster. The New England Journal of Medicine 2002; 347(1): 340-347. Go to original source... Go to PubMed...
    14. Štork J, et al. Dermatovenerologie. Praha: Galén, 2008: 502.
    15. Shaiks S, Christopher NTa. Evalution and management of herpes zoster ophtalmicus. America Family Physician 2002; 66(1): 1723-1732.
    16. Arvin AM. Cell-mediated imunity to varicella-zoster virus. J. Infect. Dis. 1992; 66: 35-41. Go to original source... Go to PubMed...
    17. Chalupa P, Bartošová D. Infekce viry herpes zoster. Doporučené postupy pro praktické lékaře. http://www.cls.cz/dp.
    18. Stankus SJ, Dlukopolski M, Packer D. Management of herpes zoster (shingles) and postherpetic neuralgia. American Academy Physician 2000; 61: 2437-2444.
    19. Cohen I, Brynelo PA, Straus SE, Krause PR. Recent advances in Varicella-zoster virus infection. Annals of Internal Medicine 1999; 130(11): 922-932. Go to original source... Go to PubMed...
    20. Stránská R, Schuurman R, de Vos M, Van Loon AM. Routine use of a highly automated and internally controled real-time PCR assay for the diagnosis herpes simplex and varicella-zoster virus infections. J. Clin. Virol. 2003; 30(1): 39-44. Go to original source... Go to PubMed...
    21. Weller TH, Coons AH. Fluorescent antibody studies with agents of varicella and herpes zoster propagated in vitro. Proc Soc Exp Biol Med 1954; 86: 789-794. Go to original source... Go to PubMed...
    22. Holten K. B. Treatment of herpes zoster. American Family Physician 2006; 5: 882-885.
    23. Whitley RJ, Weiss H, Gnann JW, Tyring S, Mertz GJ, Pallas GJ, et al. Acyclovir with and without prednosine for the treatment of herpes zoster. A randomized-placebo controled trial. The National Institute Allergy and Infectious Diseases Collaborative Antiviral Study Group. Ann. Int. Med. 1996, 125(5): 376-383. Go to original source... Go to PubMed...
    24. Zicha J. Antiherpetická virostatika. Zpravodaj klinické a farmakologické farmacie 1997; 11: 9-13.
    25. Hakl M. Základní principy farmakoterapie chronické bolesti. Neurol. pro praxi 2005; 2: 95-98.
    26. Hakl M, Hřib R. Farmakologická léčba chronické nenádorové bolesti. Interní Med. 2005; 2: 97-100.

    Return to the content


    Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.